← Leaderboards
Anand S Mehta
Callisto Pharmaceuticals, Inc.
$15,171,193
Attributed
$19,761,166
Total exposure
17
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$19,761,166 · 17
By mechanism
R01$8,664,105 · 4
U01$6,647,673 · 4
R41$1,827,746 · 4
R21$1,242,212 · 3
R42$1,233,950 · 1
R33$145,480 · 1
Top collaborators
- Richard R Drake8 shared
- Yujin Hoshida5 shared
- Jorge A Marrero5 shared
- Amit Singal5 shared
- Peggi M Angel3 shared
- Brian B Haab2 shared
- Stephen Castellino1 shared
- Danielle Scott1 shared
Others in their field
Top investigators on “Glycoproteins”
- Dennis R. Burton · Scripps Research Institute$211,788,189
- Joseph G Sodroski · University Of Pennsylvania$47,423,604
- Kartik Chandran · Albert Einstein College Of Medicine$41,665,810
- Erica Ollmann Saphire · Scripps Research Institute$32,718,575
- Robert F Garry · Scripps Research Institute, The$32,430,244
- James E Crowe · Vanderbilt University Medical Center$32,099,289
Research focus
GlycoproteinsSerumGlycosylationMalignant NeoplasmsPolysaccharidesPrimary Carcinoma Of The Liver CellsProteinsSamplingCirrhosisDetectionValidationBaseMalignant Neoplasm Of LiverBiological MarkersCohortLectinDiagnosisLiver DiseasesLinkAntibodiesKininogensPerformanceFucoseEarly Diagnosis
Grant awards (59)
Glycan Biomarkers for Cholangiocarcinoma$671,384
R01 · FY2025 · CA · contact PI
Translating glycans into biomarkers$570,754
R01 · FY2025 · CA · contact PI
Translating glycans into biomarkers$596,254
R01 · FY2024 · CA · contact PI
Glycopathology of HCC: identification of the source cells of serum fucosylation$603,318
U01 · FY2023 · CA · contact PI
Translation of a biomarker panel for the early detection of hepatocellular carcinoma$405,980
R01 · FY2023 · CA · contact PI
Glycopathology of HCC: identification of the source cells of serum fucosylation$603,318
U01 · FY2022 · CA · contact PI
Translation of a biomarker panel for the early detection of hepatocellular carcinoma$521,077
R01 · FY2022 · CA · contact PI
Development of the GlycoHCCTyper for the early detection of HCC$428,443
R41 · FY2022 · CA
Translation of a biomarker panel for the early detection of hepatocellular carcinoma$531,711
R01 · FY2021 · CA · contact PI
Glycopathology of HCC: identification of the source cells of serum fucosylation$413,676
U01 · FY2021 · CA · contact PI
Simplified Glycan Profiling Workflows of Captured Immune Glycoproteins and Cells$254,212
U01 · FY2021 · CA
Glycopathology of HCC: identification of the source cells of serum fucosylation$615,632
U01 · FY2020 · CA · contact PI
Translation of a biomarker panel for the early detection of hepatocellular carcinoma$518,911
R01 · FY2020 · CA · contact PI
Simplified Glycan Profiling Workflows of Captured Immune Glycoproteins and Cells$281,657
U01 · FY2020 · CA
Development of a Tryptic-Lectin ELISA for the early detection of HCC$198,361
R21 · FY2020 · CA · contact PI
Glycopathology of HCC: identification of the source cells of serum fucosylation$552,594
U01 · FY2019 · CA · contact PI
Translation of a biomarker panel for the early detection of hepatocellular carcinoma$546,516
R01 · FY2019 · CA · contact PI
Glyco-typer: an antibody capture glycan imaging methodology$391,987
R21 · FY2019 · CA · contact PI
Simplified Glycan Profiling Workflows of Captured Immune Glycoproteins and Cells$281,657
U01 · FY2019 · CA
Development of the GlycoFibrotyper for detection of liver fibrosis$223,055
R41 · FY2019 · DK
Development of a Tryptic-Lectin ELISA for the early detection of HCC$177,263
R21 · FY2019 · CA · contact PI
Glyco-typer: an antibody capture glycan imaging methodology$339,424
R21 · FY2018 · CA · contact PI
Identification of Altered Glycan and Glycoproteins in Viral Induced Liver Cancer$329,172
R01 · FY2016 · CA · contact PI
Aberrantly secreted glycoproteins as markers of liver cancer$289,144
U01 · FY2016 · CA · contact PI
Identification of Altered Glycan and Glycoproteins in Viral Induced Liver Cancer$163,284
R01 · FY2016 · CA · contact PI
Identification of Altered Glycan and Glycoproteins in Viral Induced Liver Cancer$469,333
R01 · FY2015 · CA · contact PI
Aberrantly secreted glycoproteins as markers of liver cancer$336,596
U01 · FY2015 · CA · contact PI
Identification of Altered Glycan and Glycoproteins in Viral Induced Liver Cancer$55,064
R01 · FY2015 · CA · contact PI
Identification of Altered Glycan and Glycoproteins in Viral Induced Liver Cancer$16,465
R01 · FY2015 · CA · contact PI
Identification of Altered Glycan and Glycoproteins in Viral Induced Liver Cancer$15,841
R01 · FY2015 · CA · contact PI
Identification of Altered Glycan and Glycoproteins in Viral Induced Liver Cancer$321,060
R01 · FY2014 · CA · contact PI
Aberrantly secreted glycoproteins as markers of liver cancer$311,766
U01 · FY2014 · CA · contact PI
Identification of Altered Glycan and Glycoproteins in Viral Induced Liver Cancer$203,178
R01 · FY2014 · CA · contact PI
Predicting HCC through Glycomics$22,577
R01 · FY2014 · CA · contact PI
Aberrantly secreted glycoproteins as markers of liver cancer$316,400
U01 · FY2013 · CA · contact PI
Identification of Altered Glycan and Glycoproteins in Viral Induced Liver Cancer$311,949
R01 · FY2013 · CA · contact PI
Identification of Altered Glycan and Glycoproteins in Viral Induced Liver Cancer$346,329
R01 · FY2012 · CA · contact PI
Aberrantly secreted glycoproteins as markers of liver cancer$293,548
U01 · FY2012 · CA · contact PI
Identification of Altered Glycan and Glycoproteins in Viral Induced Liver Cancer$332,149
R01 · FY2010 · CA · contact PI
HCC diagnostics defined by fucosylated serum biomarkers$517,164
R42 · FY2009 · CA · contact PI
Identification of Altered Glycan and Glycoproteins in Viral Induced Liver Cancer$326,354
R01 · FY2009 · CA · contact PI
Identification of Altered Glycan and Glycoproteins in Viral Induced Liver Cancer$306,072
R01 · FY2009 · CA · contact PI
HCC diagnostics defined by fucosylated serum biomarkers$151,800
R42 · FY2009 · CA · contact PI
HCC diagnostics defined by fucosylated serum biomarkers$564,986
R42 · FY2008 · CA · contact PI
Identification of Altered Glycan and Glycoproteins in Viral Induced Liver Cancer$317,565
R01 · FY2008 · CA · contact PI
Identification of Altered Glycan and Glycoproteins in Viral Induced Liver Cancer$369,942
R01 · FY2007 · CA · contact PI
Proteasome mediated degradation of HBV protein$284,454
U01 · FY2007 · AI · contact PI
Identification of Altered Glycan and Glycoproteins in Viral Induced Liver Cancer$395,184
R01 · FY2006 · CA · contact PI
Proteasome mediated degradation of HBV protein$292,950
U01 · FY2006 · AI · contact PI
HCC diagnostics defined by fucosylated serum biomarkers$216,299
R41 · FY2006 · CA · contact PI
Proteasome mediated degradation of HBV protein$300,000
U01 · FY2005 · AI
Proteasome mediated degradation of HBV protein$179,991
U01 · FY2004 · AI
Proteasome mediated degradation of HBV protein$125,610
U01 · FY2004 · AI
Identification of serum glycosylation markers of HCC$92,631
R33 · FY2004 · CA
Identification of serum glycosylation markers of HCC$52,849
R33 · FY2004 · CA
Proteasome mediated degradation of HBV protein$311,150
U01 · FY2003 · AI
New hepatitis B small molecule inhibitors$590,721
R41 · FY2002 · AI
Identification of serum glycosylation markers of HCC$135,177
R21 · FY2002 · CA
New hepatitis B small molecule inhibitors$369,228
R41 · FY2001 · AI